NJ High Court Takes On Nix Of $83M J&J, Bard Mesh Verdicts

By Bill Wichert (October 25, 2021, 3:38 PM EDT) -- The New Jersey Supreme Court will evaluate whether a state appeals court was wrong to throw out verdicts totaling $83 million against Johnson & Johnson's Ethicon unit and C.R. Bard Inc. due to the exclusion of evidence that the companies' pelvic mesh products were cleared through the U.S. Food and Drug Administration's 510(k) process....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!